The good outcome observed in adult T-ALL patients is consistent with the fact that deletions in CDKN2A/B are more frequent in cortical/mature T-ALL subgroups, which are characterized by their better outcome when compared with more immature subtypes [70,71,74]. The gene discussed is CDKN2A; the disease is acute lymphoblastic leukemia.